Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:422-429
Published online before print November 16, 2006, doi: 10.1161/01.ATV.0000252826.96134.21
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/2/422    most recent
01.ATV.0000252826.96134.21v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughan, S. C.
Right arrow Articles by Watson, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughan, S. C.
Right arrow Articles by Watson, S. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE
Related Collections
Right arrow Thrombin
Right arrow Aggregation
Right arrow Signal transduction
Right arrow Other anticoagulants
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:422.)
© 2007 American Heart Association, Inc.


Thrombosis

GPVI Potentiation of Platelet Activation by Thrombin and Adhesion Molecules Independent of Src Kinases and Syk

Sascha C. Hughan; Craig E. Hughes; Owen J.T. McCarty; Edina Schweighoffer; Izoumroud Soultanova; Jerry Ware; Victor L.J. Tybulewicz; Steve P. Watson

From the Centre for Cardiovascular Sciences (S.C.H., C.E.H., O.J.T.M., S.P.W.), Institute of Biomedical Research, University of Birmingham, UK; the National Institute for Medical Research (E.S., V.L.J.T.), London, UK; Australian Centre for Blood Diseases (S.C.H.), Monash University, Melbourne, Victoria, Australia; and the Department of Physiology and Biophysics (I.S., J.W.), University of Arkansas for Medical Sciences, Little Rock. Current affiliation for O.J.T.M.: Department of Biomedical Engineering, Oregon Health and Science University, Portland, Ore.

Correspondence to Dr Sascha C. Hughan, Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia, 3004. E-mail Sascha.hughan{at}med.monash.edu.au

Objective— The present study investigates the role of Src and Syk tyrosine kinases in signaling by G-protein coupled and platelet adhesion receptors.

Methods and Results— Using Syk–/– platelets or the Src kinase inhibitor PP2, we demonstrate a critical role for Src and Syk kinases in mediating lamellipodia formation on VWF, collagen, CRP, fibrinogen, and fibronectin. In all cases, the spreading defect was overcome by addition of thrombin. Conversely, platelet aggregation and {alpha}IIbß3 activation induced by thrombin was similar to controls, arguing against a functional role for Src and Syk in {alpha}IIbß3 activation. Unexpectedly, CRP potentiated integrin {alpha}IIbß3 activation and platelet aggregation induced by subthreshold concentrations of thrombin in Syk–/– platelets or in the presence of the Src kinase inhibitor PP2. Potentiation in the presence of PP2 was lost in the absence of FcR{gamma}-chain or GPVI confirming that it was mediated through the immunoglobulin receptor. Further delineation of this PP2-resistant synergy revealed that PAR4 could trigger the enhanced response in combination with CRP.

Conclusions— We show that Syk is critical for lamellipodia formation on a range of immobilized proteins but that this can be overcome by addition of thrombin. Further, we reveal a novel role for GPVI in supporting thrombin-induced activation, independent of Syk and Src kinases.

We show a critical role for Syk in platelet spreading mediated by adhesion receptors that can be overcome by addition of G protein agonists. In addition, we demonstrate for the first time a synergistic pathway between GPVI and thrombin which promotes integrin {alpha}IIbß3 activation independent of Syk and Src kinases.


Key Words: platelets • GPVI signaling • Src kinases • Syk • thrombin




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. A. Karim, W. Choi, and S. W. Whiteheart
Primary Platelet Signaling Cascades and Integrin-mediated Signaling Control ADP-ribosylation Factor (Arf) 6-GTP Levels during Platelet Activation and Aggregation
J. Biol. Chem., May 2, 2008; 283(18): 11995 - 12003.
[Abstract] [Full Text] [PDF]